Guidelines on Bladder Cancer Muscle-invasive and Metastatic (2012 Update)
A. Stenzl (chairman), J.A. Witjes (vice-chairman), E. Compérat, N.C. Cowan, M. De Santis, M. Kuczyk, T. Lebret, M.J. Ribal, A. Sherif
European Association of Urology (EAU) 2012
Bladder Cancer Treatment (PDQ®)
National Cancer Institute (NCI) 2012
Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS) (2011 Update)
M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt
European Association of Urology (EAU) 2011
Guideline for the Management of Nonmuscle Invasive Bladder Cancer: (Stages Ta,T1, and Tis): Update (2007) (Reviewed and validity confirmed 2010.)
M. Craig Hall, M.D.; Chair Sam S. Chang, M.D.; Vice-chair Guido Dalbagni, M.D.; Raj Som Pruthi, M.D.; Paul F. Schellhammer, M.D.; John Derek Seigne, M.B.; Eila Curlee Skinner, M.D.; J. Stuart Wolf, Jr., M.D.
American Urological Association (AUA) 2010
National Guideline Clearinghouse Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic
A. Stenzl; N.C. Cowan; M. De Santis; G. Jakse; M. Kuczyk; A.S. Merseburger; M.J. Ribal; A. Sherif; J.A. Witjes
Agency for Healthcare Research and Quality (AHRQ) 2008
NETS Module 10: Bladder, Prostate, and Testicular Malignancies
Prepared by Scientific Applications International Corporation (SAIC)
Centers for Disease Control and Prevention (CDC) 2009
Interventional Procedure Guidance for Electrically-Stimulated Intravesical Chemotherapy for Superficial Bladder Cancer (IPG277)(Minor update 2012)
National Institute for Health and Clinical Excellence (NICE) 2008
Pretreatment Staging of Invasive Bladder Cancer
John R. Leyendecker, MD; Isaac R. Francis, MD; David D. Casalino, MD; Ronald S. Arellano, MD; Deborah A. Baumgarten, MD, MPH; Nancy S. Curry, MD; Manjiri Dighe, MD; Gary M. Israel, MD; Nicholas Papanicolaou, MD; Srinivasa Prasad, MD; Parvati Ramchandani, MD; Erick M. Remer, MD; Sheila Sheth, MD; Pat Fulgham, MD.
American College of Radiology (ACR) 2009